| Schizophrenia Study In Adults (NCT00049946) | GlaxoSmithKline | 2002-10-01 |
| Airway Inflammation In Patients With Chronic Obstructive Pulmonary Disease (NCT00268177) | GlaxoSmithKline | 2002-10-01 |
| Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults (NCT00048360) | GlaxoSmithKline | 2002-10-01 |
| Rosiglitazone And Plaque Study for Type 2 Diabetes Mellitus (NCT00231387) | GlaxoSmithKline | 2002-09-01 |
| Reacto & Immunogenicity of TF Formulation of Influsplit SSW® 2002/03 v/s Std Formulation of Influsplit SSW® 2002/03 (NCT00731029) | GlaxoSmithKline | 2002-09-01 |
| GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin (NCT00044343) | GlaxoSmithKline | 2002-09-01 |
| Major Depressive Disorder Study In Adults (NCT00049972) | GlaxoSmithKline | 2002-09-01 |
| Prevention of Seasonal Affective Disorder (NCT00046241) | GlaxoSmithKline | 2002-09-01 |
| Prevention of Seasonal Affective Disorder (NCT00046449) | GlaxoSmithKline | 2002-09-01 |
| Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin (NCT00329225) | GlaxoSmithKline | 2002-09-01 |
| A Study To Investigate The Antidepressant Effect Of Lamotrigine In Patients With Bipolar Disorder Using Lithium (NCT00224510) | GlaxoSmithKline | 2002-08-01 |
| Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung Cancer (NCT00320359) | GlaxoSmithKline | 2002-08-01 |
| Drug Use Investigation for IMURAN (Azathioprine) Tablet (Hepatic Transplantation) (NCT01390766) | GlaxoSmithKline | 2002-08-01 |
| The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC) (NCT00043862) | GlaxoSmithKline | 2002-08-01 |
| Immunogenicity & Safety Study of a Meningococcal Serogroup B Vaccine Given in a 3 Dose Schedule to Healthy Adolescents Aged 12-18 Yrs (NCT00137917) | GlaxoSmithKline | 2002-07-01 |
| A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients (NCT00046332) | GlaxoSmithKline | 2002-06-01 |
| Study to Test the Efficacy of the Vaccine GSK 249553 in Treating Non-small-cell Lung Cancer After Tumour Removal by Surgery (NCT00290355) | GlaxoSmithKline | 2002-05-28 |
| Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity (NCT00197249) | GlaxoSmithKline | 2002-05-01 |
| BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (NCT00839397) | GlaxoSmithKline | 2002-05-01 |
| Study to Assess the Incidence of Intussusception in Children < 2 Years of Age in Singapore (NCT01177839) | GlaxoSmithKline | 2002-05-01 |
| Effect Of Rosiglitazone On Carotid Intima Media Thickness In Patients With Insulin Resistance Syndrome And/Or Type 2 Diabetes (NCT00306644) | GlaxoSmithKline | 2002-05-01 |
| Efficacy and Safety In Poorly Controlled Type 2 Diabetics (NCT00044460) | GlaxoSmithKline | 2002-05-01 |
| Long-term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164 (NCT00650104) | GlaxoSmithKline | 2002-05-01 |
| Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years (NCT00383591) | GlaxoSmithKline | 2002-03-01 |
| Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT Vaccine and Hib-MenC-TT Vaccine in Infants (NCT00135486) | GlaxoSmithKline | 2002-03-01 |
| Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy (NCT00043914) | GlaxoSmithKline | 2002-01-14 |
| Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR (NCT00043888) | GlaxoSmithKline | 2002-01-01 |
| ThromboEmbolism Prevention Efficacy and Safety Trial (TEMPEST) (NCT00041509) | GlaxoSmithKline | 2002-01-01 |
| Comparison of GSK Biologicals' Reduced Antigen Diphtheria and Tetanus Toxoids and Acellular Pertussis- Inactivated Poliovirus Vaccine, to BoostrixTM and Inactivated Poliovirus Vaccine Administered Separately and With Revaxis® (NCT01277705) | GlaxoSmithKline | 2002-01-01 |
| Sumatriptan and Naratriptan Pregnancy Registry (NCT01059604) | GlaxoSmithKline | 2001-12-01 |
| Oral Topotecan As A Radiosensitizing Agent In Rectal Cancer (NCT00158886) | GlaxoSmithKline | 2001-11-08 |
| Advair Pediatric Once-Daily (NCT00920959) | GlaxoSmithKline | 2001-11-01 |
| Prevention Of Recurrence Of Atrial Fibrillation (NCT00041496) | GlaxoSmithKline | 2001-11-01 |
| To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV (NCT00346892) | GlaxoSmithKline | 2001-11-01 |
| Lamotrigine Pregnancy Registry (LAM05) (NCT01064297) | GlaxoSmithKline | 2001-11-01 |
| A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO). (NCT00038961) | GlaxoSmithKline | 2001-11-01 |
| Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer (NCT00049998) | GlaxoSmithKline | 2001-10-01 |
| To Evaluate Immunogenicity & Safety of GSK Bio's DTPa-HBV-IPV/Hib (Mixed Vaccine) and DTPa-IPV/Hib + HBV Vaccines (NCT00366366) | GlaxoSmithKline | 2001-09-01 |
| A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors (NCT00046111) | GlaxoSmithKline | 2001-09-01 |
| Drug Use Investigation for IMIGRAN Tablet (NCT01376141) | GlaxoSmithKline | 2001-09-01 |
| Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma (NCT00992992) | GlaxoSmithKline | 2001-06-28 |
| Comparison of the Efficacy and Tolerability of the Addition of AVANDIA to Submaximal Doses of Metformin (NCT00501020) | GlaxoSmithKline | 2001-06-05 |
| Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And Hypertension (NCT00060918) | GlaxoSmithKline | 2001-06-01 |
| Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension (NCT00060931) | GlaxoSmithKline | 2001-06-01 |
| Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months (NCT00385320) | GlaxoSmithKline | 2001-05-31 |
| Twinrix Pregnancy Registry (NCT03619590) | GlaxoSmithKline | 2001-05-18 |
| Special Drug Use Investigation for PAXIL Tablet (Long-term) (NCT01371448) | GlaxoSmithKline | 2001-05-01 |
| Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure (NCT00025727) | GlaxoSmithKline | 2001-05-01 |
| Drug Use Investigation for PAXIL Tablet (NCT01371435) | GlaxoSmithKline | 2001-04-01 |
| Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults (NCT00043927) | GlaxoSmithKline | 2001-04-01 |
| RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (NCT00379769) | GlaxoSmithKline | 2001-04-01 |
| Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs (NCT00011895) | GlaxoSmithKline | 2001-02-01 |
| Efficacy Study of HPV-16/18 Vaccine (GSK 580299) to Prevent HPV-16 and/or -18 Cervical Infection in Young Healthy Women (NCT00689741) | GlaxoSmithKline | 2001-01-01 |
| Immunogenicity and Safety of Primary and Booster Vaccination With DTPa-HBV-IPV/Hib Vaccine (NCT00880477) | GlaxoSmithKline | 2001-01-01 |
| Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine at Different Viral Concentrations in Healthy Infants (NCT00429481) | GlaxoSmithKline | 2001-01-01 |
| Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug (NCT00043901) | GlaxoSmithKline | 2000-12-01 |
| Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer (NCT00276276) | GlaxoSmithKline | 2000-11-01 |
| Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore. (NCT00388440) | GlaxoSmithKline | 2000-11-01 |
| Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants. (NCT00729001) | GlaxoSmithKline | 2000-11-01 |
| A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal Vaccine (NCT00119743) | GlaxoSmithKline | 2000-10-01 |
| Safety and Immunogenicity Study of MEDI-517 (GSK 580299) With or Without Adjuvant in Healthy Adult Females (NCT00693615) | GlaxoSmithKline | 2000-10-01 |
| Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants (NCT00879827) | GlaxoSmithKline | 2000-09-01 |
| Pediatric Epilepsy Study in Subjects 1-24 Months (NCT00044278) | GlaxoSmithKline | 2000-09-01 |
| Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT00268216) | GlaxoSmithKline | 2000-09-01 |
| Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as Control (NCT00697866) | GlaxoSmithKline | 2000-08-01 |
| Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine in Healthy Infants (NCT00425737) | GlaxoSmithKline | 2000-08-01 |
| AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide Alone (NCT00333723) | GlaxoSmithKline | 2000-07-28 |
| Pediatric Epilepsy Trial in Subjects 1-24 Months (NCT00043875) | GlaxoSmithKline | 2000-05-01 |
| Iodine-131 Anti-B1 Antibody Consolidation for Patients With Non-Hodgkin's Lymphoma Following First-line CHOP (NCT01868035) | GlaxoSmithKline | 2000-05-01 |
| Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00005865) | GlaxoSmithKline | 2000-04-01 |
| Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV) (NCT00140725) | GlaxoSmithKline | 2000-04-01 |
| Rosiglitazone on Microalbuminuria in Type 2 Diabetics (NCT00500955) | GlaxoSmithKline | 2000-04-01 |
| Safety and Efficacy of SmithKline Beecham (GlaxoSmithKline [GSK]) Biologicals' Candidate Adjuvanted Vaccines (287615) (NCT00508833) | GlaxoSmithKline | 2000-03-01 |
| Open Label Multicenter Study of CVP Followed by Iodine-131 Anti-B1 Antibody for Subjects With Untreated Low-Grade Non Hodgkin's Lymphoma. (NCT01663714) | GlaxoSmithKline | 2000-02-01 |
| Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine (NCT01457560) | GlaxoSmithKline | 2000-02-01 |
| Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide (NCT00279045) | GlaxoSmithKline | 2000-01-03 |
| Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Pre-liver Transplant Patients 18 Years of Age (NCT00697554) | GlaxoSmithKline | 2000-01-01 |
| Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years (NCT00383383) | GlaxoSmithKline | 1999-12-01 |
| Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years (NCT00383227) | GlaxoSmithKline | 1999-12-01 |
| Pediatric Asthma Study Using Stepwise Treatment With Two Food And Drug Administration Approved Asthma Medications (NCT00158834) | GlaxoSmithKline | 1999-11-01 |
| Immunogenicity and Safety of an Adjuvanted HBV Vaccine Compared to Engerix™-B, in a Non-responder Population ≥ 15y (NCT00698061) | GlaxoSmithKline | 1999-11-01 |
| Dose-Comparison Study to Evaluate the Safety and Immunogenicity of MEDI-517 (GSK 580299) in Healthy Adult Females (NCT00693966) | GlaxoSmithKline | 1999-10-01 |
| Drug Use Investigation for FLOLAN (Epoprostenol) Injection 0.5mg・1.5mg (NCT01387191) | GlaxoSmithKline | 1999-08-01 |
| Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Non Hodgkin's Lymphoma (NHL) Patients With Greater Than 25% Bone Marrow Involvement (NCT00992758) | GlaxoSmithKline | 1999-05-28 |
| Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 Genotype (NCT00697749) | GlaxoSmithKline | 1999-04-01 |
| Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15y (NCT00696917) | GlaxoSmithKline | 1999-04-01 |
| 506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents (NCT00003635) | GlaxoSmithKline | 1999-01-01 |
| Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately (NCT01457508) | GlaxoSmithKline | 1999-01-01 |
| Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults (NCT00697853) | GlaxoSmithKline | 1998-11-01 |
| Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly (NCT01457495) | GlaxoSmithKline | 1998-09-01 |
| Expanded Access Study Of BEXXAR® For Low Grade And Transformed Low-Grade Non-Hodgkin's Lymphoma (NCT00268203) | GlaxoSmithKline | 1998-09-01 |
| A Randomized Study of Iodine-131 Anti-b1 Antibody Versus Anti-b1 Antibody in Chemotherapy-relapsed/Refractory Low-grade or Transformed Low-grade Non-Hodgkin's Lymphoma (NHL) (NCT01573000) | GlaxoSmithKline | 1998-09-01 |
| Study of Safety and Efficacy of a Sequential Regimen Consisting of Three Cycles of Fludarabine Followed by Tositumomab and Iodine I 131 Tositumomab (NCT00933335) | GlaxoSmithKline | 1998-08-01 |
| Study of Iodine-131 Anti-B1 Antibody for Patients With Non Hodgkin's Lymphoma Who Have Previously Received Rituximab (NCT00996593) | GlaxoSmithKline | 1998-07-01 |
| Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology (NCT00950755) | GlaxoSmithKline | 1998-06-01 |
| Retreatment of Patients With Non-Hodgkin's Lymphoma Who Have Previously Responded to Iodine-131 Anti B1 Antibody (NCT00938041) | GlaxoSmithKline | 1998-04-01 |
| Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy Adolescents (NCT00697775) | GlaxoSmithKline | 1998-03-01 |
| Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis Vaccine (NCT01262924) | GlaxoSmithKline | 1997-10-01 |
| Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults (NCT01267058) | GlaxoSmithKline | 1997-09-01 |
| Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y (NCT00698906) | GlaxoSmithKline | 1997-06-01 |